Fidelity International’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$279K Buy
+3,948
New +$213K ﹤0.01% 983
2025
Q4
Sell
-12,505
Closed -$696K 1078
2025
Q3
$696K Buy
+12,505
New +$670K ﹤0.01% 809
2024
Q4
Sell
-4,245
Closed -$339K 976
2024
Q3
$339K Buy
+4,245
New +$319K ﹤0.01% 811
2022
Q3
Sell
-69,044
Closed -$5.98M 878
2022
Q2
$5.98M Sell
69,044
-88,004
-56% -$8.25M 0.01% 564
2022
Q1
$17M Buy
+157,048
New +$16.2M 0.02% 469
2015
Q3
Sell
-1,049,476
Closed -$25.8M 536
2015
Q2
$25.8M Hold
1,049,476
0.08% 230
2015
Q1
$26.3M Buy
1,049,476
+172,612
+20% +$4.1M 0.08% 223
2014
Q4
$20.3M Buy
876,864
+73,912
+9% +$1.69M 0.07% 259
2014
Q3
$18.8M Sell
802,952
-50,480
-6% -$1.18M 0.07% 251
2014
Q2
$19.8M Buy
853,432
+28,300
+3% +$625K 0.07% 255
2014
Q1
$17.6M Buy
825,132
+6,468
+0.8% +$146K 0.06% 279
2013
Q4
$19.4M Buy
818,664
+379,464
+86% +$8.22M 0.08% 236
2013
Q3
$8.79M Buy
+439,200
New +$8.33M 0.04% 323

Other funds holding TECH

Fidelity International's TECH Position: Q2 2026 in Review

Fidelity International opened a new position in Bio-Techne (TECH) in Q2 2026: 3,948 shares worth $279K. The stake represents ﹤0.01% of the portfolio and ranks #983 among its holdings. This is a return to the name: Fidelity International previously reported a position in TECH as recently as Q3 2025.

Fidelity International first reported a position in TECH in Q3 2013 and has held it in 13 quarters since. The position peaked at $26.3M in Q1 2015. 595 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Fidelity International held 3,948 shares of Bio-Techne worth $279K as of Q2 2026.
  • Bio-Techne was a new Fidelity International position in Q2 2026.
  • Bio-Techne made up ﹤0.01% of Fidelity International's portfolio in Q2 2026, its #983 holding.
  • Fidelity International first reported a position in Bio-Techne in Q3 2013 and has held it in 13 quarters since.
  • Fidelity International's Bio-Techne position peaked at $26.3M in Q1 2015.
  • 595 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Fidelity International's 13F filing for Q2 2026, filed 13 Aug 2026.